There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just<a class="excerpt-read-more" href=" More ...
Big pharma’s pushing for PBS funding, and it’s kickstarting a shift to healthier snacks, smaller portions, and more ...
Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.
Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
The Eli Lilly submission has not been made public, but people briefed on its contents confirmed the inclusion. A PBS listing means the government subsidises most of the cost of a drug. Ozempic is ...
Eli Lilly’s profit doubled in the fourth quarter ... weight people lose while taking the injections. They compete with Ozempic and Wegovy from the Danish drugmaker Novo Nordisk, which also ...